Abbott Shines as Xience Stent Beats Taxus

Abbott said this morning that its Xience stent outperformed Boston Scientific’s Taxus on several measures in a two-year study. The results mean the stent is likely to get the green light from the FDA soon — and they also evoke an interesting backstory that reads like a who’s who of the medical device industry. A [...]